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In This IssueLipids Seed a-Synuclein Aggregation
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Defects in glucocerebrosidase promote the accumulation of glucosylceramide
lipids in the lysosome, the cause of Gaucher disease. Mutations in this enzyme
are also associated with Parkinson’s disease, but how they contribute to
disease progression has been unclear. Mazzulli et al. show that glucosylcera-
mide accumulation in the lysosome promotes a-synuclein aggregation, a hall-
mark of Parkinson’s disease. Moreover, the authors show that a-synuclein also
inhibits glucocerebrosidase, creating a feedback loop that amplifies the levels
of toxic a -synuclein oligomers and contributes to neurodegeneration.Selective Target for Glioma Stem Cells
PAGE 53
Cancer stem cells (CSCs) play a crucial role in tumor maintenance and are
potential targets for cancer therapies. Eyler et al. demonstrate that endogenous NOS2-derived nitric oxide supports glioma
stem cell (GSC) proliferation, partially through inhibition of the cell-cycle inhibitor CDA1. Inhibitors of NOS2 decrease
GSC growth in vitro as well as in xenografts, with minimal effects on normal neural stem cells. Inhibitors of NOS2 have
been associated with minimal toxicity in other diseases, enhancing the translational potential for these results.The Final Cut for Demethylation
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Elucidating the mechanism of active DNA demethylation in vivo, Cortellino et al. show that the final step of mammalian DNA
demethylation is mediated by the DNA repair pathway. The authors demonstrate that the repair enzyme thymine DNA glyco-
sylase (TDG) is necessary for protection of CpG islands from hypermethylation and for active demethylation of a subset of
promoters and enhancers during development. TDG interacts with the deaminase AID and the damage response protein
GADD45a, coordinating a two-step mechanism for DNA demethylation in mammals, whereby 5-methylcytosine and 5-hy-
droxymethylcytosine are first deaminated by AID, followed by TDG-mediated thymine and 5-hydroxymethyluracil excision
repair.Elongating Mediator’s Role in Transcription
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The Mediator complex is well known as a regulator of Pol II transcription initia-
tion. Now, Takahashi et al. describe a new role for Mediator in controlling Pol II
elongation, showing that one Mediator subunit, Med26, contains a docking site
for a complex of elongation factors, including P-TEFb and those known to fuse
via translocation to the MLL protein in leukemia. By providing new insight into
regulation of Pol II transcription, these results suggest amodel for themolecular
basis of misregulated transcription in mixed lineage leukemias.A Time for Leading and a Time for Lagging
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Using purified proteins and yeast extracts, Heller et al. develop an in vitro assay
for replication initiation and use it to define the order of events during eukaryotic
replication. They show that two kinases required for replication initiation, DDK and S-CDK, act sequentially to recruit proteins
to the replication origin. Surprisingly, they also find that the recruitment of leading and lagging strand DNA polymerases
occurs at different times relative to the unwinding of DNA at the origin.Cell 146, July 8, 2011 ª2011 Elsevier Inc. 1
Safe Space for Membrane Protein Acrobatics
PAGE 134
In eukaryotes, the ribosome-Sec61 translocon complex (RTC) inserts proteins
into membranes cotranslationally. For type II signal anchor proteins, this
process ultimately results in an inverted orientation in which the N terminus
faces the cytoplasm. Devaraneni et al. delineate four distinct steps that allow
type II proteins to achieve this inverted final topology. They show that, although
the N terminus heads into the translocon first, the protective environment of the
RTC allows the transmembrane domain to invert, leading to the proper final
topology.Synthetic Enhancers Get Loopy
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DNA looping at enhancers is thought to be an integral part of transcriptional
regulation. Amit et al. examine synthetic enhancer modules and show thatcontrol of looping leads to discrete levels of expression or repression. A combination of experimental and modeling data
reveals that driver sequences within the enhancer, transcription factor binding sites, and poised polymerases collaborate
to regulate transcriptional output via control of DNA loop formation.X Inactivation Gets a Foothold
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The long noncoding Xist RNA coats one X chromosome in female mammals and recruits silencing complexes to inactivate it.
Jeon and Lee now define a trio of epigenetically regulated YY1-binding sites as the primary loading site for Xist and show that
YY1, a knownDNA-binding protein, directly recruits Xist to the chromosome. Together, the data support amodel in which YY1
acts as adaptor between regulatory RNA and chromatin targets.Slit Slots Neurons into the Right Layer
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In the brain, neuronal connections are often organized in stacks, with each layer
in the stack containing synapses with similar function. In this issue, Xiao et al.
show that the secreted axon guidance molecule Slit, which binds to collagen
covering the zebrafish tectum, signals via the Robo2 receptor to direct retinal
axons and tectal dendrites to their correct layers. The findings provide evidence
for how a neuronal guidance molecule bound to an extracellular matrix compo-
nent patterns neural laminae.Cav-eat for Cell Invasion
PAGE 148Forces produced by the cellular microenvironment contribute to both developmental morphogenesis and tumor growth.
Goetz et al. show that caveolin-1, best known for its role inmembrane invagination, drives both physiological and pathological
remodeling of the microenvironment. Fibroblasts expressing caveolin-1 are elongated and produce a highly organized and
tensile matrix that reshapes other cells and modifies their migration properties. In tumors, this force-dependent architectural
remodeling of the microenvironment facilitates invasion and metastasis, revealing unexpected roles for caveolin-1 in both
normal tissue and cancer.Cell 146, July 8, 2011 ª2011 Elsevier Inc. 3
